Literature DB >> 23672460

Brain glucose-6-phosphate dehydrogenase protects against endogenous oxidative DNA damage and neurodegeneration in aged mice.

Winnie Jeng1, Margaret M Loniewska, Peter G Wells.   

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) protects the embryo from endogenous and xenobiotic-enhanced oxidative DNA damage and embryopathies. Here we show in aged mice that G6PD similarly protects against endogenous reactive oxygen species (ROS)-mediated neurodegeneration. In G6PD-normal (G6PD(+/+)) and heterozygous (G6PD(+/def)) and homozygous (G6PD(def/def)) G6PD-deficient male and female mice at about 2 years of age, oxidative DNA damage in various brain regions was assessed by 8-oxo-2'-deoxyguanosine formation using high-performance liquid chromatography and immunohistochemistry. Morphological changes in brain sections were assessed by H&E staining. DNA oxidation was increased in G6PD(def/def) mice in the cortex (p < 0.02), hippocampus (p < 0.01) and cerebellum (p < 0.006) compared to G6PD(+/+) mice, and was localized to distinct cell types. Histologically, in G6PD(+/def) mice, enhanced regionally and cellularly specific neurodegenerative changes were observed in those brain regions exhibiting elevated DNA oxidation, with a 53% reduction in the Purkinje cell count. These results show G6PD is important in protecting against the neurodegenerative effects of endogenous ROS in aging, and suggest that common hereditary G6PD deficiencies may constitute a risk factor for some neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23672460      PMCID: PMC3715834          DOI: 10.1021/cn400079y

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  45 in total

1.  Reduced 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-initiated oxidative DNA damage and neurodegeneration in prostaglandin H synthase-1 knockout mice.

Authors:  Winnie Jeng; Peter G Wells
Journal:  ACS Chem Neurosci       Date:  2010-02-23       Impact factor: 4.418

2.  The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease.

Authors:  A M Palmer
Journal:  J Neural Transm (Vienna)       Date:  1999       Impact factor: 3.575

3.  Glucose-6-phosphate dehydrogenase and glutathione reductase support antioxidant enzymes in nerves and muscles of rats during nerve regeneration.

Authors:  P Ninfali; C Cuppini; S Marinoni
Journal:  Restor Neurol Neurosci       Date:  1996-01-01       Impact factor: 2.406

4.  Moderate G6PD deficiency increases mutation rates in the brain of mice.

Authors:  Klaus Felix; Lynne D Rockwood; Walter Pretsch; Jagadeesan Nair; Helmut Bartsch; Georg Wilhelm Bornkamm; Siegfried Janz
Journal:  Free Radic Biol Med       Date:  2002-04-01       Impact factor: 7.376

5.  Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease.

Authors:  R L Russell; S L Siedlak; A K Raina; J M Bautista; M A Smith; G Perry
Journal:  Arch Biochem Biophys       Date:  1999-10-15       Impact factor: 4.013

Review 6.  The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis.

Authors:  Ella T Nkhoma; Charles Poole; Vani Vannappagari; Susan A Hall; Ernest Beutler
Journal:  Blood Cells Mol Dis       Date:  2009-02-23       Impact factor: 3.039

7.  Decreased catalase activity is the underlying mechanism of oxidant susceptibility in glucose-6-phosphate dehydrogenase-deficient erythrocytes.

Authors:  M D Scott; T C Wagner; D T Chiu
Journal:  Biochim Biophys Acta       Date:  1993-04-30

8.  DNA oxidation as a potential molecular mechanism mediating drug-induced birth defects: phenytoin and structurally related teratogens initiate the formation of 8-hydroxy-2'-deoxyguanosine in vitro and in vivo in murine maternal hepatic and embryonic tissues.

Authors:  L Liu; P G Wells
Journal:  Free Radic Biol Med       Date:  1995-11       Impact factor: 7.376

9.  The function of catalase-bound NADPH.

Authors:  H N Kirkman; S Galiano; G F Gaetani
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

Review 10.  Oxidative stress, glutamate, and neurodegenerative disorders.

Authors:  J T Coyle; P Puttfarcken
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

View more
  19 in total

1.  Middle aged turn point in parameters of oxidative stress and glucose catabolism in mouse cerebellum during lifespan: minor effects of every-other-day fasting.

Authors:  Maria M Bayliak; Nadia M Mosiichuk; Oksana M Sorochynska; Oksana V Kuzniak; Lesia O Sishchuk; Anastasiia O Hrushchenko; Alina O Semchuk; Taras V Pryimak; Yulia V Vasylyk; Dmytro V Gospodaryov; Kenneth B Storey; Olga Garaschuk; Volodymyr I Lushchak
Journal:  Biogerontology       Date:  2021-03-30       Impact factor: 4.277

2.  G6PD as a predictive marker for glioma risk, prognosis and chemosensitivity.

Authors:  Chin-An Yang; Hsi-Yuan Huang; Cheng-Li Lin; Jan-Gowth Chang
Journal:  J Neurooncol       Date:  2018-05-29       Impact factor: 4.130

3.  Expression signatures of early-stage and advanced medaka melanomas.

Authors:  Barbara Klotz; Susanne Kneitz; Martina Regensburger; Lena Hahn; Michael Dannemann; Janet Kelso; Birgit Nickel; Yuan Lu; William Boswell; John Postlethwait; Wesley Warren; Manfred Kunz; Ronald B Walter; Manfred Schartl
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2017-11-21       Impact factor: 3.228

Review 4.  Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives.

Authors:  Adriana A Garcia; Ana Koperniku; Julio C B Ferreira; Daria Mochly-Rosen
Journal:  Trends Pharmacol Sci       Date:  2021-08-10       Impact factor: 17.638

Review 5.  Boosting the Discovery of Small Molecule Inhibitors of Glucose-6-Phosphate Dehydrogenase for the Treatment of Cancer, Infectious Diseases, and Inflammation.

Authors:  Ana Koperniku; Adriana A Garcia; Daria Mochly-Rosen
Journal:  J Med Chem       Date:  2022-03-03       Impact factor: 8.039

Review 6.  Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities.

Authors:  Juan I Sbodio; Solomon H Snyder; Bindu D Paul
Journal:  Antioxid Redox Signal       Date:  2018-05-04       Impact factor: 8.401

7.  A Dual Role of ATM in Ischemic Preconditioning and Ischemic Injury.

Authors:  Guang-Hui Xie; Han-Jun Dai; Fang Liu; Ying-Pei Zhang; Li Zhu; Jun-Jie Nie; Jian-Hua Wu
Journal:  Cell Mol Neurobiol       Date:  2019-12-16       Impact factor: 5.046

Review 8.  Glial Cell Line-Derived Neurotrophic Factor and Focal Ischemic Stroke.

Authors:  Zhe Zhang; Grace Y Sun; Shinghua Ding
Journal:  Neurochem Res       Date:  2021-02-16       Impact factor: 4.414

9.  Determination of Highly Sensitive Biological Cell Model Systems to Screen BPA-Related Health Hazards Using Pathway Studio.

Authors:  Do-Yeal Ryu; Md Saidur Rahman; Myung-Geol Pang
Journal:  Int J Mol Sci       Date:  2017-09-06       Impact factor: 5.923

10.  G6PD protects from oxidative damage and improves healthspan in mice.

Authors:  Sandrina Nóbrega-Pereira; Pablo J Fernandez-Marcos; Thomas Brioche; Mari Carmen Gomez-Cabrera; Andrea Salvador-Pascual; Juana M Flores; Jose Viña; Manuel Serrano
Journal:  Nat Commun       Date:  2016-03-15       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.